Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 27Neoplasms 20Cancer Pain 10Colonic Neoplasms 7Breakthrough Pain 7Agnosia 7Breast Neoplasms 5Rectal Neoplasms 4Prostatic Neoplasms 4Lung Neoplasms 4Head and Neck Neoplasms 4Chronic Pain 4Urinary Bladder Neoplasms 3Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Pain, Postoperative 3Lymphoma, Follicular 3Breakthrough Cancer Pain 3Waldenstrom Macroglobulinemia 2Uterine Cervical Neoplasms 2Thrombocythemia, Essential 2Sezary Syndrome 2Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Pleural Effusion, Malignant 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Myeloproliferative Disorders 2Mycosis Fungoides 2

Interventions

Fentanyl 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Abdominal Cancer Surgeries × Fentanyl × Clear all
NCT07214714 2025-10-09

Hemodynamic and Cardiac Effects of Dexmedetomidine Versus Fentanyl by Intravenous Infusion as Adjuncts to General Anesthesia in Patients Undergoing Major Abdominal Cancer Surgeries.

Assiut University

Phase 4 Not yet recruiting
70 enrolled

Abdominal Cancer Surgeries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡